He-San Luo Selected Research

Therapeutics

1/2020	Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study
1/2019	Definitive chemoradiation therapy or surgery for clinical T1-3N0-1M0 thoracic esophageal squamous cell carcinoma: A propensity score matching analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

He-San Luo Research Topics

Disease

8	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021 - 12/2017
4	Esophageal Squamous Cell Carcinoma 10/2021 - 12/2017
4	Neoplasms (Cancer) 01/2020 - 04/2011
2	Esophageal Neoplasms (Esophageal Cancer) 10/2019 - 10/2018
1	Triple Negative Breast Neoplasms 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Carcinogenesis 03/2019
1	Chylothorax 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Adenoma (Adenomas) 04/2011
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Lymphatic Metastasis 04/2011

Drug/Important Bio-Agent (IBA)

1	taxaneIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	AnthracyclinesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 03/2019
1	MicroRNAs (MicroRNA)IBA 03/2019
1	Olive OilIBA 01/2019
1	Casein Kinases (Casein Kinase)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	Small Interfering RNA (siRNA)IBA 04/2011

Therapy/Procedure

5	Radiotherapy 10/2021 - 10/2018
2	Chemoradiotherapy 10/2020 - 12/2017
2	Therapeutics 01/2020 - 01/2019
2	Consolidation Chemotherapy 10/2018 - 12/2017
1	Neoadjuvant Therapy 01/2021
1	Immunotherapy 01/2020
1	Esophagectomy 01/2019